BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Alvine Pharmaceuticals, Inc. 

75 Shoreway Rd.
Suite B
San Carlos  California  94070   U.S.A.
Phone: 650-632-1645 Fax: 650-632-3396


SEARCH JOBS










 Company News
Alvine Pharmaceuticals, Inc. Doses First Patient in Phase 2b Trial for ALV003 in Celiac Disease 10/29/2013 10:04:04 AM    More...
Alvine Pharmaceuticals, Inc. Lands $70 Million From AbbVie (ABBV) for Celiac Disease Drug 5/14/2013 10:09:01 AM    More...
AbbVie (ABBV) and Alvine Pharmaceuticals, Inc. to Collaborate on Investigational Oral Therapy for Celiac Disease 5/14/2013 9:50:35 AM    More...
Alvine Pharmaceuticals, Inc. Presents Celiac Disease Symptom Frequency and Severity Study Results at the 2012 American College of Gastroenterology Meeting 10/24/2012 9:18:31 AM    More...
Alvine Pharmaceuticals, Inc. ALV003 Receives Fast Track Designation From the FDA for the Potential Treatment of Celiac Disease 9/5/2012 9:32:28 AM    More...
Alvine Pharmaceuticals, Inc.'s ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover Information Inc. for a Rare Second Year 11/29/2011 10:07:27 AM    More...
Alvine Pharmaceuticals, Inc. Presents Additional Efficacy Data From Phase 2a Trial of ALV003 in Celiac Disease Patients 10/24/2011 9:04:01 AM    More...
Alvine Pharmaceuticals, Inc. Announces Positive Results From Phase 2a Trial of ALV003 in Celiac Disease Patients 10/11/2011 7:03:58 AM    More...
Alvine Pharmaceuticals, Inc. Announces Upcoming Presentation of Phase 2a ALV003 Data in Patients With Celiac Disease 9/22/2011 8:57:20 AM    More...
Alvine Pharmaceuticals, Inc. Appoints James D. Watson as Senior Vice President and Chief Business Officer 9/13/2011 10:25:00 AM    More...
123